• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.35%

    Geron Corporation (GERN)

    -NasdaqGS
    2.64 Up 0.03(0.96%) Feb 9, 4:00PM EST
    Prev Close:2.62
    Open:2.56
    Bid:2.60 x 1000
    Ask:2.76 x 400
    1y Target Est:7.50
    Beta:2.5957
    Next Earnings Date:N/A
    Day's Range:2.52 - 2.74
    52wk Range:2.52 - 5.30
    Volume:2,458,546
    Avg Vol (3m):3,079,920
    Market Cap:417.71M
    P/E (ttm):N/A
    EPS (ttm):-0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GERN

    Comparison

    Symbol% ChgMkt Cap
    GERNUp 0.96%417.71M
    BMYUp 0.49%101.80B
    GSKDown 0.33%95.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.00
    Quarterly EPS Est (Dec-15) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback